Why Choose Ace Therapeutics' In Vitro Screening Services for Ocular Biomarkers?

The primary goal of biomarker discovery is to screen the safety and efficacy of new drugs at different stages of development. In vitro screening studies can identify the most promising potential biomarkers early in drug development, paving the way for subsequent development of new drugs and formulation of novel therapies.

Ace Therapeutics provides a high-throughput in vitro screening method for the discovery of ocular biomarkers. This approach typically uses our multi-omic biomarker analysis platform, powerful bioinformatics, and proprietary validation strategies, and leverages a range of cell types associated with ocular disease.

General Strategy

Ace Therapeutics' team of ocular biomarker experts has developed a comprehensive knowledge framework for in vitro ocular biomarker screening. Ideally, our in vitro screening approach first generates a baseline profile of the cell (eg, genomic and/or proteomic profile), a step that relies heavily on our multi-omics analysis platform. They are subsequently treated with the study drug, and bioinformatics methods were used to analyze the profiles of responder versus non-responder samples. Finally, discover potential biomarkers that can be used for downstream decision-making. And select appropriate in vitro and/or in vivo models for validation of identification of targets and hypothesis testing.

Our Knowledge Framework for In Vitro Ocular Biomarker Screening Services

What attracts our customers is that our in vitro screening service is customized according to the customer's project. Through our in vitro screening expertise and services, you will get composite ocular biomarker with higher accuracy, not just a single ocular biomarker. Contact our scientists for your custom project!

Workflow of Ocular Biomarker Custom Services at Ace Therapeutics.

Service Highlights

Our in vitro screening services for ocular biomarkers can provide a wealth of useful information, providing cost-effectiveness for client project development, and developing beneficial novel therapies early in drug discovery. You can use our in vitro screening services for ocular biomarkers to solve the following problems for you, including but not limited to:

• Discover and validate the mechanism of action of your ophthalmic drug with ocular biomarker in vitro screening services.
• Determine the cytogenetic characterization of drug-associated genetic signatures.
• Developing potential ocular biomarkers.
• Provide advice and guidance on in vivo animal model selection during preclinical testing.

In the field of ocular biomarker research, Ace Therapeutics has demonstrated outstanding results. Our expert team has successfully developed ocular biomarkers for many pharmaceutical companies and research institutions to meet their scientific research needs. If you are conducting ophthalmology research and looking for related in vitro ocular biomarker screening services, Ace Therapeutics is the place for you. Please feel free to contact us. We look forward to becoming your trustworthy partner.

• In Vivo Screening Services for Ocular Biomarkers
• Ocular Candidate Biomarker Optimization Services
• Potential Ocular Biomarker Validation Services

• * Name:
• Phone:
• * Email:
• * Services or Products of Interest:
• Project Description:
• * All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

  * Tick to confirm the Research Use Only (RUO) statement.

• Submit